These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 33738588)
1. Cancer stem cells in colorectal cancer and the association with chemotherapy resistance. Lei X; He Q; Li Z; Zou Q; Xu P; Yu H; Ding Y; Zhu W Med Oncol; 2021 Mar; 38(4):43. PubMed ID: 33738588 [TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc. Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling. Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919 [TBL] [Abstract][Full Text] [Related]
4. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma. Das PK; Islam F; Lam AK Cells; 2020 Jun; 9(6):. PubMed ID: 32503256 [TBL] [Abstract][Full Text] [Related]
5. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer. Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894 [TBL] [Abstract][Full Text] [Related]
6. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation. Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235 [TBL] [Abstract][Full Text] [Related]
7. Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480. Butler SJ; Richardson L; Farias N; Morrison J; Coomber BL Biochem Biophys Res Commun; 2017 Aug; 490(1):29-35. PubMed ID: 28576498 [TBL] [Abstract][Full Text] [Related]
8. [Research progression in colorectal cancer stem cells]. Wu TY; Cui L Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355 [TBL] [Abstract][Full Text] [Related]
9. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells. Shi L; Xi J; Xu X; Peng B; Zhang B Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544 [TBL] [Abstract][Full Text] [Related]
10. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment. Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640 [TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer. Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714 [TBL] [Abstract][Full Text] [Related]
13. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells. Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042 [TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor. Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357 [TBL] [Abstract][Full Text] [Related]
15. Targeting Colorectal Cancer Stem Cells as an Effective Treatment for Colorectal Cancer. Ma YS; Li W; Liu Y; Shi Y; Lin QL; Fu D Technol Cancer Res Treat; 2020; 19():1533033819892261. PubMed ID: 32748700 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
17. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner. Prabhu VV; Allen JE; Dicker DT; El-Deiry WS Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124 [TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance. De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206 [TBL] [Abstract][Full Text] [Related]
19. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687 [TBL] [Abstract][Full Text] [Related]
20. Can nanomedicines kill cancer stem cells? Zhao Y; Alakhova DY; Kabanov AV Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]